<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ONXX</title>
    <link />
    <description>Headlines for Onyx Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Positive Data on Array Oncology Candidate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101945/positive-data-on-array-oncology-candidate.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 19 Jun 2013 20:45:01 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Pharmaceuticals Inc. (ONXX): Today's Featured Drugs Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11954265/1/onyx-pharmaceuticals-inc-onxx-todays-featured-drugs-laggard.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 18 Jun 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>The Top 5 Diseases Caused by Obesity</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/16/the-top-5-diseases-caused-by-obesity/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 16 Jun 2013 14:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/06/13/merrill-lynch-top-biotechnology-stocks-to-buy-for-big-gains/.aspx</link>
      <author>247wallst</author>
      <pubDate>Thu, 13 Jun 2013 08:15:59 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-1</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1498062-onyx-pharmaceuticals-inc-presents-at-goldman-sachs-34th-annual-global-healthcare-conference-jun-12-2013-10-00-am.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 12 Jun 2013 16:40:04 GMT</pubDate>
    </item>
    <item>
      <title>Drug Rejected! Let's Rejoice?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/11/drug-rejected-lets-rejoice/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 11 Jun 2013 16:15:00 GMT</pubDate>
    </item>
    <item>
      <title>DVAX, RDY, ONXX, ALXN And VRX, 5 Health Care Stocks Pushing The Sector Lower</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11946050/1/dvax-rdy-onxx-alxn-and-vrx-5-health-care-stocks-pushing-the-sector-lower.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 10 Jun 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Aveo's Future Depends on Triple-Negative Breast Cancer</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11943098/1/aveos-future-depends-on-triple-negative-breast-cancer.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 06 Jun 2013 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Revlimid Gains, Celgene Loses</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/05/celgene-gains-new-indication-for-blockbuster-revli/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 05 Jun 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Celgene at ASCO: Ho-Hum, Ho-Hum, and Hmmm</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/04/celgene-at-asco-ho-hum-ho-hum-and-hmmm/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 04 Jun 2013 14:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Positive Data on Bayer/Onyx's Nexavar - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100724/positive-data-on-bayer-onyxs-nexavar.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 04 Jun 2013 00:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Stock Falls On Unusually High Volume (ONXX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11940088/1/onyx-stock-falls-on-unusually-high-volume-onxx.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 03 Jun 2013 15:38:00 GMT</pubDate>
    </item>
    <item>
      <title>Correction to Stories on Thyroid Cancer Drug From Bayer, Onyx</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130602-000262&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Sun, 02 Jun 2013 15:28:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Thyroid Cancer Drug From Bayer, Onyx Helps Halt Disease's Progress</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130602-000256&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Sun, 02 Jun 2013 13:13:00 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Phase 3 Nexavar DECISION Trial Shows Significant Improvement in Progression-Free Survival in Pa</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3639880/onyx-phase-3-nexavar-decision-trial-shows-significant-improvement-in-progression-.aspx</link>
      <author>Benzinga</author>
      <pubDate>Sun, 02 Jun 2013 09:28:07 GMT</pubDate>
    </item>
    <item>
      <title>ASCO '13: Onyx's Nexavar Delays Growth of Thyroid Cancer</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11937844/1/asco-13-onyxs-nexavar-delays-growth-of-thyroid-cancer.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Sun, 02 Jun 2013 07:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Your Best Investing Ideas</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/01/tackling-cancer-your-best-investing-ideas/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 01 Jun 2013 14:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Europe is Positive on these 2 Drugs</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/31/europe-is-positive-on-these-2-drugs/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 31 May 2013 19:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Pharma to Hold Call to Discuss Phase 3 DECISION Data at 2013 ASCO</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3638489/onyx-pharma-to-hold-call-to-discuss-phase-3-decision-data-at-2013-asco.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 31 May 2013 16:03:50 GMT</pubDate>
    </item>
    <item>
      <title>Aveo Chairman: Expect 'Consequences" From Kidney Cancer Drug Debacle</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11936199/1/aveo-chairman-expect-consequences-from-kidney-cancer-drug-debacle.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 29 May 2013 11:50:00 GMT</pubDate>
    </item>
  </channel>
</rss>
